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Abstract 
     The ultimate objective of nanoparticle-based therapy is to functionalize 
nanomedicines in a micro-disease environment without any side effects.  Here, we 
reveal that our pH-responsive nitroxide radical-containing nanoparticles (RNPpH) 
disintegrate within the renal acidic lesion and act as scavengers of reactive oxygen 
species (ROS), leading to a relief of acute kidney injury (AKI).  RNPpH was prepared 
using amphiphilic block copolymers possessing 2,2,6,6-tetramethylpiperidine-N-oxyl 
(TEMPO) moieties via amine linkage as a side chain of the hydrophobic segment.  The 
self-assembled RNPpH disintegrated at pH below 7.0 because of a protonation of the 
amino groups in the hydrophobic core of the nanoparticles, thereby resulting in an 
improvement in ROS scavenging activity.  Using a renal ischemia-reperfusion AKI 
model in mice, the therapeutic effect of RNPpH on ROS damage was evaluated.  Unlike 
the RNP without pH-triggered disintegration (RNPNon-pH), the RNPpH showed extremely 
high ROS scavenging activity and renal protective effects.  It is interesting to note that 
the side effect of nitroxide radicals was markedly suppressed due to the 
compartmentalization of nitroxide radicals in the core of RNPpH in untargeted area.  
The morphology changes in RNPpH were confirmed by analyzing electron spin 
resonance spectra, and these findings provide the evidence of the real therapeutic effect 
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of the environment-sensitive specific disintegration of nanoparticles in vivo. 
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Introduction 
Acute kidney injury (AKI) is evoked by multiple disorder and the morbidity and 
mortality rates of AKI patients have been keeping high level despite significant 
advances in the management of the disease in recent years [ 1].  One potential 
mechanism for the irreversible damage is the generation of reactive oxygen species 
(ROS), which leads to the stimulation of pro-apoptotic mediators, inflammatory 
cytokines and further oxidative stress [ 2 - 4 ].  Redox-targeted therapies using 
antioxidants have been attracted much attention and widely attempted clinically.  
Though they worked to some extent, it remains incomplete [5
To improve the therapeutic efficiencies of drugs, the precise control of 
pharmacokinetics is crucial.  Drug delivery nanoparticles using polymeric micelles or 
liposomes are able to control the drug pharmacokinetics and some of them have already 
].  Since redox reaction is 
one of the most important events in biological activity, severe and unexpected side 
effects were caused if antioxidant turns around the body after high-dose administration.  
To obtain therapeutic efficiency and suppress unwanted effects, the innovative strategy 
must be required.  If drug, which effectively scavenges ROS excessively generated at 
specific-lesion, retaining dormant character under untargeted area, it can be safe and 
effective medication. 
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been commercialized for anti-cancer therapy [6-8].  Nanoparticles are known to 
accumulate in specific regions because of the changes in the specific vascular 
microenvironment [ 9].  More than 90 % of the nanoparticles, however, spread 
non-specifically in vivo after systemic administration [10,11].  Active targeting is one 
of the challenges to improve nanoparticle accumulation in specific disease areas; 
however, to date, no remarkable effect on its biodistribution has been reported [12].  
When ligands with high specificity are installed on the carrier surface, its blood 
circulation tendency often decreases due to the lowered colloidal stability [13].  Even 
if the ligand-installed carrier works well in vitro, it is very difficult to effectively work 
under in vivo conditions.  One promising target to improve the efficiency of 
nanotherapy is “on-off regulation”, whereby the nanoparticle is dormant in non-target 
tissue and is activated in the target area, thus improving treatment outcomes and 
decreasing side effects [14
Here, we propose a promising therapy, “Environmental-Signal-Enhanced Polymer 
Drug Therapy” (ESEPT) for AKI (see Fig. 1).  The main concepts of ESEPT are: (1) 
installation of the drug in a hydrophobic segment of an amphiphilic block copolymer 
via a covalent linkage; (2) self-assembly of the block copolymer to compartmentalize 
the drugs in the core of the nanoparticle; and (3) disintegration of the nanoparticle in 
].   
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response to a signal, such as pH, in the disease environment.  Thus, the ESEPT 
strategy improves the therapeutic efficiency and suppresses the significant side effects.  
The polymer designed for ESEPT in this study is a poly(ethylene 
glycol)-b-poly(methylstyrene) (PEG-b-PMS) block copolymer, attached to 
2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) via an amine linkage (PEG-b-PMNT) 
(see Fig. 1) [15].  PEG-b-PMNT forms a core-shell type of self-assembling polymeric 
micelle in aqueous media, and it disintegrates under acidic conditions due to the 
protonation of amino groups located in the core of the nitroxide-radical-containing 
particle (RNPpH) [16,17].  Simultaneously, the RNPpH exposes the nitroxide radicals, 
which can catalytically scavenge ROS [18,19].  Therefore, we hypothesized that the 
treatment of AKI is a suitable target of ESEPT by RNPpH.  The aim of this study was to 
demonstrate a rational strategy for ESEPT using a renal ischemia-reperfusion (IR) 
induced AKI model in mice.  If RNPpH can disintegrate and scavenge ROS in response 
to low pH in renal ischemic regions [ 20
 
], it might become an ideal therapeutic 
nanoparticle for AKI.   
8 
 
Methods 
Preparation of RNPpH  
pH-responsive RNPpH was prepared by a self-assembling PEG-b-PMNT block 
copolymers, as previously reported [15,16].  Briefly, 
MeO-PEG-b-poly(chloromethylstyrene) (PCMS) was synthesized by the radical 
telomerization of chloromethylstyrene (CMS) using MeO-PEG-SH (Mn = 5,000) as a 
telogen. To obtain PEG-b-PMNT, the chloromethyl groups on the PCMS segment of the 
block copolymer were converted to nitroxide radicals via the amination of 
MeO-PEG-b-PCMS with 4-amino-TEMPO in DMSO.  The RNPpH was prepared from 
MeO-PEG-b-PMNT by the dialysis method. Final concentration of RNPpH was adjusted 
by PBS.  Please see Supplementary Methods about dialysis method.   
 
Preparation of RNPNon-pH  
Non-pH-responsive RNPNon-pH was prepared by a self-assembling amphiphilic 
block copolymer (PEG-b-PMOT) composed of the PEG segment and the PMS segment 
possessing TEMPO moieties as a side chain via ether linkage, as show in Fig. S1.  
Please see Supplementary Methods about detailed preparation method.   
 
Measurement of the scavenging activity of RNP against superoxide 
The spin trap method was performed using 5,5-dimethyl-1-pyrroline-N-oxide 
(DMPO) as a spin-trapping agent to detect superoxide generated by the reaction of 
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xanthine with xanthine oxidase (XOD).  Briefly, 5 μL of 10 U/mL XOD solution were 
added to the mixture of xanthine solution (5 μL, 20 mM), DMPO solution (10 μL, 1 
mM) in milliQ water containing diethylenediaminepentaacetate (0.1 mM) and 
Britton-Robinson buffer (70 μL) (pH 6.0 and pH 7.4) prepared from a stock solution 
containing 1 M phosphoric acid, 1 M boric acid and 1 M acetic acid, and by adjusting 
the pH value with NaOH in the presence or absence of RNP solution (10 μL) (nitroxide 
concentration: 3.3 μM).  The mixture was immediately transferred to a capillary tube, 
followed by measurement of the ESR spectrum.  The final concentrations of the 
DMPO, xanthine, XOD, and TEMPO radicals in RNP were 100 μM, 1 mM, 0.5 U/mL 
and 0.33 μM, respectively.  Because the ESR spectra of DMPO overlap with ESR 
spectra of RNP, signal intensities of DMPO were subtracted from the RNP spectra (see 
Supplementary Fig. S2). 
 
Animals 
Male ICR mice between 9 and 11 weeks old were maintained in the experimental 
animal facilities at the University of Tsukuba.  All experiments were performed 
according to the Guide for the Care and Use of Laboratory Animals at the University of 
Tsukuba.  
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Renal ischemia-reperfusion   
Animals were anesthetized initially with pentobarbital sodium (40 mg/kg).  
After right heminephrectomy, the left renal pedicle was clamped through flank incisions 
for 50 min using a microvascular clip to produce ischemia and then reperfusion was 
performed.  In addition, another group of mice was subjected to flank incision and 
right heminephrectomy as the sham-operated control group.  The animals were 
randomly divided to receive intravenous injection of RNPpH (3 mg/kg), RNPNon-pH (1.5 
mg/kg), 4-hydroxyl-TEMPO (0.4 mg/kg), 4-amino-TEMPO (0.4 mg/kg), and vehicle 
(PBS) at 5 min after reperfusion. 
 
Assessment of renal function  
Blood samples were collected by intracardiac puncture using heparined syringe at 
24 h after reperfusion.  Then, plasma samples were obtained by centrifugation (6,200 
rpm, 2000 g, 10 min) of the blood.  Plasma samples were assayed for BUN and Cr 
using a Fuji Dri-chem 3500 (Fuji-Film, Tokyo, Japan). 
 
Morphological studies 
Please see Supplementary Methods. 
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Measurement of renal superoxide production  
To determine superoxide production, kidneys excised from mice were 
homogenized in sucrose buffer (0.32 M sucrose, 10 mM Tris-HCl, pH 7.4) on ice with a 
homogenizer.  The kidney lysate (100 μL) was moved to a 96-well black plate 
(NUNC) containing 3.3 mM dihydroethidium (DHE; Wako), followed by incubation at 
37 ºC for 20 min.  The fluorescent intensity of each well was measured at a spectrum 
wavelength of excitation at 530 nm and emission at 620 nm.  DHE alone was read to 
calculate a zero-point.  Superoxide values, which subtracted the zero-point value, were 
expressed as intensity per 100 μg of protein.  To determine superoxide production 
histologically, kidneys excised from mice were embedded in Tissue-Tek oxytetracycline 
(OTC) compound (Funakoshi, Japan) on the dry ice.  Later, the tissue samples were 
sliced into 20-μm cryo-sections using a cryotome (Leica).  The cryo-sections were 
then washed in PBS and stained with 1 mM DHE to detect superoxide formation.  The 
sections were incubated for 30 min with DHE solution at room temperature, mounted 
with Prolong Gold anti-fade reagent (Invitrogen), and observed under a microscope 
(Leica). 
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Cytokine measurements 
Plasma levels of cytokines were determined at 24 h after reperfusion. IL-6 was 
measured by a commercial available enzyme-linked immunoassay kit (Thermo 
Scientific Pierce Protein Research Products) according to manufacturer’s instrument. 
 
Measurement of TBARS 
The degree of lipid peroxidation in the kidney tissue was determined by 
measuring the malondialdehyde (MDA) levels with TBARS.  Kidney was frozen and 
stored at -80 ˚C until the assay.  Briefly, a 10 % (wt/vol) kidney homogenate was 
prepared in 0.1 M PB solution containing 1 mM EDTA followed by centrifugation at 
600 g for 15 min at 4 ˚C.  An aliquot of the supernatant was added to the reaction 
mixture containing 8 % SDS, 20 % acetic acid, 0.8 % thiobarbituric acid, and water.  
After incubation at 95 ˚C for 1 h, the amount of MDA formed in the reaction mixture 
was measured by a spectrophotometer at an absorbance of 532 nm.  MDA was used as 
the standard, and TBARS values were expressed as nmol per mg protein.   
 
ESR Measurement of concentration of the nitroxide radicals in blood and in 
kidney.      
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  ICR mice subjected to IR injury were anesthetized via an intraperitoneal 
injection of pentobarbital sodium (40 mg/kg).  Following this, RNPs or 
low-molecular-weight TEMPO derivatives in PBS solution (nitroxide radical 
concentration: 75 mmol/kg, 350 μL) was injected intravenously.  Blood samples were 
collected from the heart using a heparinized syringe at 0.083, 0.25, 0.5, 3, 6 and 24 h 
after the administration, and the kidney was excised immediately after blood collection.  
The blood and kidney were immediately placed on ice.  Plasma samples were then 
obtained by centrifuging (6,200 rpm, 2000 g, 10 min) the blood samples. It was 
confirmed that no ESR signal was observed in the blood cell precipitates after 
centrifugation.  The ESR signal intensities in these plasma samples were measured by 
X-band ESR spectrometer (JES-TE25X; JEOL, Tokyo, Japan) at room temperature.  
In the case of the ESR intensities at 0 min, 12.5 μL of RNP solution (0.9 mg/mL) was 
added to the blood (100 μL), followed by centrifugation (6,200 rpm, 2000 g, 10 min) of 
the blood and ESR measurement, assuming that the total blood volume in mice is 80 
mL/kg.  The kidney tissue homogenates were prepared by a homogenizer.  The total 
amount of drug (nitroxide radicals + hydroxyamines) in blood and kidney were 
estimated from X-band ESR measurements of the sample after addition of K3[Fe(CN)6], 
which was prepared at 200 mM as a stock solution.  The ESR measurements were 
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carried out under the following conditions: frequency, 9.41 GHz; power, 8.00 mW; ﬁeld, 
333.8 ± 5 mT; sweep time, 1.0 min; modulation, 0.1 mT; time constant, 0.1 s. 
 
Effect of RNP on blood pressure 
Ten-weeks-old ICR mice were anesthetized with an interperitoneal injection of 
pentobarbital sodium (40 mg/kg).  Blood pressure was measured at 15 min after 
intravenous administration of PBS, RNPpH, RNPNon-pH, amino-TEMPO or 
hydroxyl-TEMPO by the indirect tail-cuff method with a blood pressure monitor (model 
MK-1030, Muromachi Kikai, Tokyo, Japan). 
 
Statistical analysis 
All values are expressed as mean ± SE. Continuous data between groups were 
compared by one-way ANOVA.  All ANOVAs were performed with ANOVA tests 
followed by Tukey’s test.  Differences with a value of P < 0.05 were considered 
statistically significant.  
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Results  
Characterization of RNP 
To test for the effectiveness of ESEPT, we prepared a 
nitroxide-radical-containing-particle without pH-triggered disintegration (RNPNon-pH) as 
a comparative nanopariticle.  Physicochemical characterization of both RNPs was 
carried out.  The size of RNPpH (average diameter, 46 nm; polydispersity factor, µ/Γ 2 
= 0.035) was almost similar to that of RNPNon-pH (average diameter, 42 nm; 
polydispersity factor, µ/Γ 2 = 0.061) (see Fig. 2a).  Fig. 2b shows the scattering 
intensities of both RNPs as a function of pH.  The light scattering intensity of RNPpH 
drastically decreased at pH values below 7.0; in contrast, there was no change in the 
case of RNPNon-pH.  According to the Rayleigh approximation (I ∝ d6, where I is the 
scattering intensity and d is the particle size), it is clear that RNPpH disintegrates at pH 
values below 7.0 and that RNPNon-pH does not disintegrate in response to pH.  To 
investigate the pH response of the superoxide scavenging activities of both RNPs, ROS 
spin-trapping experiments were carried out at pH 6.0 and 7.4.  As shown in Fig. 2c, the 
ROS scavenging activity of RNPNon-pH did not change at pH 6.0 and 7.4, whereas the 
activity of RNPpH significantly increased in response to lowered pH.  This result 
indicates that RNPpH can expose nitroxide radicals from the RNPpH core and effectively 
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scavenge superoxide anions due to the disintegration of RNPpH in response to lowered 
pH.   
 
 
Therapeutic effect of RNP on IR-AKI 
To determine the therapeutic effect of RNPpH on AKI, we prepared a renal IR 
model in mice.  Ischemic renal failure in ICR mice was initiated by right nephrectomy 
and clamping of the left renal artery and vein for 50 min.  A significant difference was 
observed in the values of blood urea nitrogen (BUN) and creatinine (Cr) 
(Supplementary Information, Fig. S3) between the sham-operated group (0 min IR) and 
50-min IR group.  At 5 min after reperfusion, 350 μL of RNPpH (3 mg/kg), RNPNon-pH 
(1.5 mg/kg), 4-amino-TEMPO (0.4 mg/kg) or 4-hydroxy-TEMPO (0.4 mg/kg) was 
administered into the tail vein of mice (body weight: ca. 35 g) subjected to renal IR.  It 
should be noted that the concentrations of nitroxide radicals in all drugs were the same, 
which were adjusted by measurements of electron spin resonance (ESR) spectra (see 
Supplementary Information, Table S1).  None of drugs caused renal dysfunction or had 
any other toxicity in normal ICR mice (Supplementary Information, Fig. S4).  At 24 h 
after reperfusion, RNPpH treated mice had BUN and Cr of 25.46 mg/dl and 0.31 mg/dl 
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versus 129.86 and 2.69 for vehicle, versus 30.27 and 0.43 for 4-hydroxy-TEMPO and 
versus 48.23 and 0.74 for 4-amino-TEMPO (see Fig. 3a and 3b).  Clearly, the RNPpH 
outperforms low-molecular-weight TEMPO derivatives in reducing renal dysfunction.  
Moreover, therapeutic effect of RNPpH was greater than that of RNPNon-pH (BUN; 34.29, 
Cr; 0.89), indicating that the disintegration of RNPpH might improve its therapeutic 
efficiency.  To further investigate renal IR injury after treatment, hematoxylin and 
eosin (HE) staining was conducted.  As shown in Fig. 3c and Table 1, HE staining 
revealed that tubular cell swelling, interstitial edema, and tubular dilatation were 
significantly more severe in the vehicle-treated IR mice than the sham-operated mice.  
Compared to other treatments, the treatment with RNPpH resulted in significantly less 
damage, similar to the measurements of BUN and Cr. 
We also investigated whether RNPpH could scavenge ROS, in particular 
superoxide, generated in the injured kidney.  As shown in Fig. 4a and 4b, the 
generation of ROS in kidney was significantly inhibited by the treatment with RNPpH in 
comparison to other treatments.  Additionally, we investigated whether RNPs can 
inhibit lipid peroxidation and generation of the inflammation cytokine.  Compared 
with other treatments, treatment with RNPpH resulted in a significant reduction of 
thiobarbituric acid reactive substance (TBARS) levels, which serve as an index of lipid 
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peroxidation in kidney, and the generation of inflammation cytokine in plasma, as can 
be seen in Fig. 4c and 4d, respectively.  In particular, TBARS level of RNPpH treated 
group was statistically lower than that of other groups as shown in Fig. 4c.  These 
results provide the reason of the high therapeutic efficiency of RNPpH. 
 
 
Conformational changes of the nanoparticle in the injured kidney 
To demonstrate the reason that RNPpH showed superior therapeutic effect on renal 
IR injury, we utilized the ESR measurement.  Since nitroxide radicals in the RNP core 
are susceptible to ESR, the spectra can provide information on morphological changes 
in the RNP.  Generally, the ESR signal of low-molecular-weight TEMPO derivatives 
shows a sharp triplet due to an interaction between the 14N nuclei and the unpaired 
electron in the dilute solution.  After preparation of RNP via the dialysis method, in 
contrast, the RNP signal became broader, indicating the location of nitroxide radicals in 
the hydrophobic solid core of RNP.  As shown in Fig. S5, both RNPs have broad ESR 
spectra at pH values above 7.4, indicating the confinement of the TEMPO radicals in 
the solid core of RNP.  With decreasing pH, the ESR signals of RNPpH gradually 
change, and triplet signals are observed under acidic pH conditions, accompanying the 
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disintegration.  This observed signal change indicates the disintegration of RNPpH.  In 
contrast, no change in the ESR spectra of RNPNon-pH was observed as a function of pH, 
indicating that RNPNon-pH possesses a core-shell type self-assembling structure 
regardless of pH change.  When the ex vivo ESR assessment is utilized after 
intravenous administration of RNPpH to mice subjected to IR injury, the changes in ESR 
spectra might be observed in renal ischemic lesion and we would verify the rational 
strategy of ESEPT in vivo.  We administered the drugs (nitroxide radical 
concentration :  75 mmol/kg) at 5 min after reperfusion and measured the ESR spectra 
of the nitroxide radicals in plasma as a function of time.  The blood samples were 
collected at 0.083, 0.25, 0.5, 3, 6 and 24 h after administration.  Fig. 5a-d shows the 
time profile of drug concentration in blood.  Generally, nitroxide radicals are reduced 
to hydroxylamine, which is not detected using ESR, by an in vivo reducing agent such 
as ascorbic acid.  Since hydroxylamine also possesses radical scavenging capacity, the 
total drug concentrations (nitroxide radicals + hydroxylamines) were determined by 
adding potassium ferricyanide (K3[Fe(CN)6]) to re-oxidize hydroxylamines to nitroxide 
radicals.  Contrary to the rapid clearance of low-molecular-weight 4-hydroxyl-TEMPO 
and 4-amino-TEMPO from the bloodstream, the ESR signals of the both RNPs were 
observed for a relatively long period of time.  The rapid clearance of 
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low-molecular-weight 4-amino-TEMPO and 4-hydroxy-TEMPO might be due to 
preferential renal clearance and diffusion across the whole body.  The insets in Fig. 
5a-d show the ESR spectra of the oxidized samples after the additions of K3[Fe(CN)6].  
Low-molecular-weight TEMPO derivatives show a clear triplet signal, as shown in Fig. 
5c-d.  In contrast, the observed ESR signals of RNPpH and RNPNon-pH were broad 
singlets in blood (see insets in Fig. 5a-b), suggesting that the TEMPO radicals are still 
located in the solid core of the polymeric micelles in blood stream.  The prevention of 
renal elimination and the long blood circulation time of RNPs can be attributed to the 
formation of polymeric micelles in blood.  Next, ESR spectra in IR-kidneys were 
measured.  Fig. 5e-h shows the time profile of drug concentration in the injured renal 
lesion.  The signals of 4-hydroxyl-TEMPO and 4-amino-TEMPO completely 
disappeared within 30 min and 6 h, respectively.  In contrast, the signals of RNPpH and 
RNPNon-pH were observed in the kidney for more than 6 h, as monitored by ESR 
spectroscopy after re-oxidation by K3[Fe(CN)6].  This long retention of nitroxide 
radicals in the kidney might be an important factor for the protection of renal function 
after IR, because excess ROS gradually continues to be generated after reperfusion [21].  
In addition, the administration of RNPpH evoked the triplet ESR signal in the IR kidney, 
whereas RNPNon-pH did not show any change from the singlet spectra.  This result 
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strongly suggests the disintegration of RNPpH at the injured kidney lesion due to the 
lowered pH.  Regardless of longest distribution of RNPNon-pH in ischemic renal lesion, 
the site-specific disintegration of RNPpH in the targeted organd would lead to the 
improved therapeutic effect on IR-AKI, as compared with RNPNon-pH.   
 
The side effects of nitroxide radicals 
Moreover, we investigated the side effects of TEMPO derivatives because 
TEMPO derivatives are known to show severe side effects; e.g., dose-related 
antihypertensive action accompanied by reflex tachycardia, increased skin temperature, 
and seizures [22].  In particular, hypotensive action would be a serious adverse event 
during the treatment and surgery.  The mean arterial blood pressure was measured at 
15 min after the intravenous administration of the drugs.  As shown in Fig. 6, 
4-amino-TEMPO and 4-hydroxy-TEMPO drastically decreases in arterial blood 
pressure.  In contrast, both RNPs inhibited the decrease in arterial blood pressure.  
There were no significant differences between the control, RNPpH and RNPNon-pH groups.  
Although the exact reason is still unknown, it is thought that the reduction of arterial 
blood pressure after administration of low-molecular-weight TEMPO derivatives is 
induced by an increase in endogenous nitric oxide (NO), resulting in vasodilatation in 
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vivo [23,24
 
].  These results demonstrate that RNPs protect against blood pressure 
fluctuations because of the encapsulation of TEMPO moieties in hydrophobic core of 
RNP in the blood stream.  
 
Discussion 
Despite significant advances in medical treatments, AKI remains a major clinical 
problem associated with considerable morbidity and mortality, which has not decreased 
significantly over the last 50 years [25].  Although many promising drugs, in particular 
antioxidants, have been developed and shown to be of benefit in experimental models of 
AKI or renal IR injury, the results of recent clinical trials investigating these promising 
drugs have been largely negative.  For example, the use of native SOD has faced a 
number of problems ranging from its rapid proteolytic degradation, immunogenicity in 
vivo to prooxidant and cytotoxic activities at higher concentrations [26].  Although 
low-molecular-weight TEMPO derivatives also show therapeutic effect on renal IR 
injuries as previous reported [27], however, they are hard to utilize in clinic due to the 
side effects such as hypotensive action.  Additionally, their preferential renal clearance 
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inhibits long-term retainment of nitroxide radicals in injured renal lesion, resulting in 
lowered therapeutic effect. 
 Unlike the concept of existing drugs, the ESEPT can control the drug 
pharmacokinetics and the pharmaceutical activity due to the “on-off regulation” of 
nanoparticle in response to signal around target tissue area.  We have to emphasize 
here that the nanoparticles possessing such signal switching characteristics tends to 
decrease their stability.  Physical entrapment of low-molecular-weight drugs causes the 
leakage of the drug from the nanoparticle into the blood stream and would decrease in 
its therapeutic efficiency and cause severe side effects.  Covalent conjugation of drug 
in hydrophobic segment of amphiphilic block copolymer, so called polymer drug, is one 
of the most important strategies to utilize “on-off” switching mechanism.  As a result, 
the RNPpH has the excellent therapeutic effect and prevents side effect for renal IR-AKI 
model in mice due to the strategy of ESEPT.  We have revealed the disintegration of 
nanoparticle in injured kidney using the ESR spectroscopy, which is provide the 
evidence of the real therapeutic effect using the environment-sensitive specific 
disintegration of nanoparticles in vivo.  Given their enhanced ability to scavenge ROS 
and reduce side effect by RNPpH, the usage of RNPpH might be a promising therapeutic 
strategy toward other oxidative stress injuries, regardless of renal IR-AKI.  Moreover, 
24 
 
we believe that the strategy of ESEPT makes a contribution in clinical practice as a new 
type of nanomedicine.   
 
 
Conclusion 
     This study demonstrates that the ESEPT strategy by pH-responsive RNPpH 
improves the therapeutic efficiency and suppresses the significant side effects, using 
renal IR-AKI model in mice, due to the morphological change in nanoparticles within 
injured kidney area.  This disintegration of RNPpH in injured kidney area was 
confirmed by ESR spectra, which is evidence of real therapeutic effect using the 
environmental-sensitive disintegration of nanoparticle worked in vivo.  Furthermore, 
the side effect of nitroxide radicals was markedly suppressed due to the 
compartmentalization of nitroxide radicals in the core of RNPpH in untargeted area.  
From these results, the RNPpH is promising as high performance nanomedicine toward 
oxidative stress injuries including renal IR-AKI. 
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Figure Legends: 
Figure 1. Schematic illustration of “Environmental-Signal-Enhanced Polymer Drug 
Therapy (ESEPT)”  
 
Figure 2.  In vitro characterization of RNPpH and RNPNon-pH (a) Size distributions 
of RNPpH (red line) and RNPNon-pH (blue line) (b) Effect of pH on the light scattering 
intensities of RNPpH (red circle) and RNPNon-pH (blue circle). The normalized scattering 
intensity (%) is expressed as the value relative to that at pH 8.2  (c) Superoxide 
scavenging activities of RNPpH and RNPNon-pH using a spin trapping agent at pH 6.0 and 
7.4.  (The bar graphs represent means ± SE for 3 independent experiments. *P <0.05, 
Student’s t-test) 
 
Figure 3.  Therapeutic effect of RNP on IR-AKI. (a) BUN and (b) Cr in plasma of 
mice at 24 h after reperfusion following 50min ischemia.  Sham veh, sham-operated 
and vehicle-treated group; IR veh, vehicle treated group; IR RNP(pH), RNPpH-treated 
group; IR RNP(non-pH), RNPNon-pH-treated group; IR AT, 4-amino-TEMPO treated 
group; IR HT, 4-hydroxy-TEMPO treated group. (Values expressed as mean ± SE. * P 
< 0.0001 as compared to IR veh. ** P < 0.005 as compared to IR veh. *** P < 0.05 as 
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compared to IR veh. n = 7, ANOVA) (c) Representative photomicrographs 
(hematoxylin and eosin staining, magnification ×200) of renal cortex of the kidneys in 
mice at 24 h after reperfusion following 50 min ischemia.  Sham/vehicle, 
sham-operated and vehicle-treated group; IR/vehicle, vehicle treated group; IR/RNPpH, 
RNPpH-treated group; IR/RNPNon-pH, RNPNon-pH-treated group; IR/AT, 4-amino-TEMPO 
treated group; IR/HT, 4-hydroxy-TEMPO treated group.   
 
Figure 4.  Suppressive effect on the generation of superoxide anion, inflammation 
cytockine and lipid oxidation.  Sham veh, sham-operated and vehicle-treated group; 
IR veh, vehicle treated group; IR RNP(pH), RNPpH-treated group; IR RNP(non-pH), 
RNPNon-pH-treated group; IR AT, 4-amino-TEMPO treated group; IR HT, 
4-hydroxy-TEMPO treated group. (a) Superoxide in renal tissue homogenate was 
measured by dihydroethidium (DHE). Superoxide values were expressed as the value 
related to fluorescent intensity of sham veh group.  (Values expressed as mean ± SE. * 
P < 0.05 as compared to IR veh. n = 5, ANOVA) (b) DHE staining in kidneys subjected 
to I/R injury. Mice were subjected to 50 min of renal ischemia or sham-operation, then 
harvested 24 h after reperfusion. The kidney sections were stained using the DHE.  (c) 
Measurement of thiobarbituric acid-reactive substances (TBARS) in the kidneys of 
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mice subjected to 50 min ischemia-reperfusion. (Values expressed as mean ± SE. * P < 
0.05 as compared to IR veh. # P < 0.001 as compared to RNPpH.  n = 5, ANOVA)   
(d) Measurement of IL-6 in the plasma of mice subjected to 50 min 
ischemia-reperfusion.  (Values expressed as mean ± SE. * P < 0.05 as compared to IR 
veh. n = 5, ANOVA)   
 
Figure 5.  Time profile of drug concentration in (a-d) blood and (e-h) injured 
kidney.  All drugs were injected from tail vein of mice subjected to 50 min ischemia at 
5 min after reperfusion. Signal intensities after adding potassium ferricyanide 
(K3[Fe(CN)6]) to re-oxidize hydroxylamines to nitroxide radicals mean the total drug 
concentrations (nitroxide radicals + hydroxylamines) (Inset) the ESR spectra of the 
oxidized samples (15 min after reperfusion) by the additions of K3[Fe(CN)6]. The 
intravenous dose was 75 μmol/kg of nitroxide concentration in all drugs to mice. (mean 
± SE, n = 5 per group).  
 
Figure 6.  The change in blood pressure at 15 min after the administration of 
drugs Mean arterial pressures were measured at 15 min after bolus injection of RNPpH, 
RNPNon-pH, 4-amino-TEMPO (AT) and 4-hydroxy-TEMPO (HT) in ICR mice. TEMPO 
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concentration of all substances was 75 μmol/kg.  (Values expressed as mean ± SE. * P 
< 0.05 as compared to PBS. n = 5, ANOVA)   
 
Table Legend: 
Table 1 Effect of RNPpH, RNPNon-pH, amino-TEMPO and treatment on morphological 
changes as assessed by histopathological examination of kidneys of the mice subjected 
to 50 min ischemia-reperfusion. 
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Methods: 
Preparation of RNPpH by dialysis method 
90 mg of MeO-PEG-b-PMNT were dissolved in 10 mL of DMF, and the polymer 
solution was transferred into a membrane tube (Spectra/Por, molecular-weight cutoff 
size: 3,500, Spectrum, USA) and then dialyzed for 24 h against 2 L of water, which was 
changed after 2, 5, 8 and 20 h. The RNPNon-pH was prepared from PEG-b-PMOT by the 
dialysis method, similar to RNPpH.  
 
Preparation of non-pH-responsive nitroxide radical-containing-particle (RNPNon-pH) 
Non-pH-responsive RNPNon-pH was prepared by a self-assembling amphiphilic block 
copolymer (PEG-b-PMOT) composed of the PEG segment and the PMS segment 
possessing TEMPO moieties as a side chain via ether linkage, as show in Fig. S1. 
Briefly, after 200 mg (25 µmol) of the MeO-PEG-b-PCMS (Mn = 8,300) were weighed 
into a 10-mL flask, a DMF (1 mL) was added, then DMF (1 mL) involved 
4-hydroxy-TEMPO (260 mg, 1.25 mmol) and sodium hydride (70.3 mg, 2.5 mmol) was 
added to the flask and stirred for 5 h at room temperature. The reacted polymer was 
filtrated and recovered by precipitation into 10 mL of cold 2-propanol (-15 °C) and 
centrifugation for 30 min at 5,000 rpm (4,500 g). In order to purify the obtained 
polymer, the precipitation-centrifugation cycle was repeated three times, followed by 
freeze-drying with benzene. The yield of the obtained PEG-b-PMOT copolymer was 
70.0 % (184 mg). 
 
Dynamic light scattering (DLS) experiments and X-band electron spin resonance 
(ESR) experiments as a function of pH      
The light scattering intensities of the pH-sensitive RNP were measured as a 
function of pH using a light scattering spectrometer (Nano ZS, ZEN3600, Malvern 
Instruments, Ltd., UK) equipped with a He-Ne laser that produces vertically polarized 
incident beams at a detection angle of 173° at 25 °C. Briefly, 3.5 mg/mL of the RNP 
solution was prepared as stock solution A after the formation of the RNPs by the 
dialysis method. Britton-Robinson buffers (100 µL each) with various pH values, which 
2 
 
were prepared from a stock solution containing 1M phosphoric acid, 1M boric acid and 
1M acetic acid and by adjusting the pH value with NaOH, were added to stock solution 
A (400 µL). The mixtures with various pH values were transferred to the cells 
immediately, followed by DLS measurement. The ESR measurements were carried out 
under the following conditions: frequency, 9.4190 GHz; power, 8.00 mW; ﬁeld, 333.8 ± 
50 mT; sweep time, 2.0 min; modulation, 0.1 mT; time constant, 0.1 s. 
 
Morphological studies 
The kidneys were fixed in a 10 % neutral buffered formalin solution and 
embedded in paraffin for use in histopathological examination.  Thick sections (4 µm) 
were cut, deparaffinized, hydrated and HE stained.  The renal sections were examined 
in a blind fashion for tubular cell swelling, interstitial edema, and tubular dilatation in 
all treatments.  Each kidney slide was examined and assigned according to the severity 
of changes using scores on a scale of none (-), mild (+), moderate (++), and severe 
(+++) damage. 
 
 
 
 
 
Figure S1.  (a) SEC diagram and (b) 1H NMR spectrum of MeO-PEG-b-PCMS and 
MeO-PEG-b-PMOT in the presence of phenylhydrazine.  (SEC apparatus, TOSOH 
HLC-8120GPC; detector, RI; column, TOSOH SUPER HZ4000+3000; solvent, THF 
(containing 2 w% triethylamine); flow rate, 0.35 mL/min; calibration, standard PEGs.) 
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Figure S2.  ESR spectrum of the RNPnon-pH and DMPO at pH 6.0 and equation of 
amount of superoxide in the present of RNPnon-pH. 
 
 
 
 
Figure S3.   The ischemic time-dependent change of plasma blood urea nitrogen 
(BUN) and plasma creatinine (Cr) on acute kidney injury induced by 
ischemia-repefusion.  (Values expressed as mean ± SE. * P < 0.0001 as compared to 0 
min. ** P < 0.01 as compared to 0 min. *** P < 0.05 as compared to 0 min. n = 5, 
ANOVA) 
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Figure S4.   Time course of plasma blood urea nitrogen (BUN), plasma creatinine 
(Cr) and body weight of normal mice after intravenous administration of PBS (black 
square), 4-amino-TEMPO (red circle), RNPpH (green triangle) and RNPNon-pH (blue 
triangle). 
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Figure S5.  X-band ESR spectra of the RNPpH (a) and RNPNon-pH (b) as a function of 
pH, at pH 5.6, 6.0, 7.4 and 8.2, in Britton-Robinson buffer prepared from a stock 
solution containing 1 M phosphoric acid, 1 M boric acid and 1 M acetic acid, and by 
adjusting the pH value with NaOH.  
 
 
 
 
 
 
 
Table S1    Total dose of administration and TEMPO 
concentrations into all drugs  
 
 
 
